Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1265

1.

Once-weekly dulaglutide versus bedtime insulin glargine, both in combination with prandial insulin lispro, in patients with type 2 diabetes (AWARD-4): a randomised, open-label, phase 3, non-inferiority study.

Blonde L, Jendle J, Gross J, Woo V, Jiang H, Fahrbach JL, Milicevic Z.

Lancet. 2015 May 23;385(9982):2057-66. doi: 10.1016/S0140-6736(15)60936-9.

PMID:
26009229
2.

Canagliflozin (Invokana). A "me-too" of the dangerous dapagliflozin.

[No authors listed]

Prescrire Int. 2015 Feb;24(157):33-5.

PMID:
25802910
3.

[The role of SGLT-2 inhibitors in the treatment of type 2 diabetes].

Rupprecht H.

MMW Fortschr Med. 2015 Jan 19;157(1):55-8. Review. German. No abstract available.

PMID:
25743304
4.

Sodium-glucose cotransporter 2 inhibitors: the new option for diabetes mellitus management.

Powell J, Miller SA, Taylor JR.

South Med J. 2015 Feb;108(2):82-90. doi: 10.14423/SMJ.0000000000000233. Review.

PMID:
25688892
5.

A new blood glucose management algorithm for type 2 diabetes: a position statement of the Australian Diabetes Society.

Gunton JE, Cheung NW, Davis TM, Zoungas S, Colagiuri S; Australian Diabetes Society.

Med J Aust. 2014 Dec 11;201(11):650-3.

PMID:
25495309
6.

Observational and clinical trial findings on the comparative effectiveness of diabetes drugs showed agreement.

Flory JH, Mushlin AI.

J Clin Epidemiol. 2015 Feb;68(2):200-10. doi: 10.1016/j.jclinepi.2014.09.001. Epub 2014 Nov 26.

PMID:
25432086
7.
8.

Characteristics and short-term outcomes of patients with type 2 diabetes mellitus treated with canagliflozin in a real-world setting.

Buysman EK, Chow W, Henk HJ, Rupnow MF.

Curr Med Res Opin. 2015 Jan;31(1):137-43. doi: 10.1185/03007995.2014.982750. Epub 2014 Nov 12.

PMID:
25356602
9.

Is your patient on target? Optimizing diabetes management.

Harmes KM, Cigolle CT.

J Fam Pract. 2014 Aug;63(8):442-51.

PMID:
25350253
10.

HbA1c as a predictor of diabetes and as an outcome in the diabetes prevention program: a randomized clinical trial.

Diabetes Prevention Program Research Group.

Diabetes Care. 2015 Jan;38(1):51-8. doi: 10.2337/dc14-0886. Epub 2014 Oct 21.

PMID:
25336746
11.
12.

Evaluating cardiovascular safety of novel therapeutic agents for the treatment of type 2 diabetes mellitus.

Azim S, Baker WL, White WB.

Curr Cardiol Rep. 2014 Nov;16(11):541. doi: 10.1007/s11886-014-0541-0. Review.

PMID:
25303895
13.

A multiplicity of targets: evaluating composite endpoint studies of the GLP-1 receptor agonists in type 2 diabetes.

Ross SA.

Curr Med Res Opin. 2015 Jan;31(1):125-35. doi: 10.1185/03007995.2014.973939. Epub 2014 Nov 4. Review.

PMID:
25299351
14.

The evaluation of clinical and cost outcomes associated with earlier initiation of insulin in patients with type 2 diabetes mellitus.

Smolen HJ, Murphy DR, Gahn JC, Yu X, Curtis BH.

J Manag Care Spec Pharm. 2014 Sep;20(9):968-84.

16.

Albiglutide: a new GLP-1 receptor agonist for the treatment of type 2 diabetes.

Trujillo JM, Nuffer W.

Ann Pharmacother. 2014 Nov;48(11):1494-501. doi: 10.1177/1060028014545807. Epub 2014 Aug 18. Review.

PMID:
25136065
17.

Efficacy and safety of oral methazolamide in patients with type 2 diabetes: a 24-week, placebo-controlled, double-blind study.

Simpson RW, Nicholson GC, Proietto J, Sarah A, Sanders KM, Phillips G, Chambers J, MacGinley R, Orford N, Walder K, Krippner G, Skoff K, Wacher VJ.

Diabetes Care. 2014 Nov;37(11):3121-3. doi: 10.2337/dc14-1038. Epub 2014 Aug 14.

PMID:
25125506
18.

Comparison of GLP-1 analogues versus sitagliptin in the management of type 2 diabetes: systematic review and meta-analysis of head-to-head studies.

Wang T, Gou Z, Wang F, Ma M, Zhai SD.

PLoS One. 2014 Aug 4;9(8):e103798. doi: 10.1371/journal.pone.0103798. eCollection 2014. Review.

19.

Linagliptin use in older individuals with type 2 diabetes.

Pratley RE.

Clin Interv Aging. 2014 Jul 16;9:1109-14. doi: 10.2147/CIA.S62877. eCollection 2014. Review.

20.

Perioperative management of diabetic patients: new controversies.

Aldam P, Levy N, Hall GM.

Br J Anaesth. 2014 Dec;113(6):906-9. doi: 10.1093/bja/aeu259. Epub 2014 Jul 30. No abstract available.

PMID:
25080432
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk